biosimilar portfolio
Scope
Date
~
-
Bio & Pharma
Biosimilar giant Celltrion to transform into drug developer
South Korean biosimilar giant Celltrion Group aims to transform into a drug developer by generating 40% of sales from new medicines by 2030 as it is...
Mar 29, 2023 (Gmt+09:00)
-
Pension funds
NPS to launch committee for portfolio firms' governance improvement
South Korea’s National Pension Service (NPS), one of the world’s largest pension funds, is slated to establish a committee to improve th...
Mar 29, 2023 (Gmt+09:00)
-
Fiber & Textile
S.Korean fashion company LF diversifies portfolio with new brand Patou
In a move to expand its range of offerings, South Korean fashion company LF Corp. has introduced a new emerging brand, Patou. As the preferences of ...
Mar 28, 2023 (Gmt+09:00)
-
Batteries
Doosan Fuel Cell teams up with Kolon Global for hydrogen fuel cell
South Korean fuel cell manufacturer Doosan Fuel Cell, and Kolon Global Corp., a South Korean company that specializes in the production of industria...
Mar 23, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
Celltrion eyes Baxter's arm as it gears up for M&As
Celltrion Inc., South Korea’s largest biosimilar maker, said on Tuesday it has studied a possible acquisition of the biopharma solutions unit ...
Mar 21, 2023 (Gmt+09:00)
-
Construction
S.Korea's builders diversify biz portfolios to waste battery, other sectors
South Korea's construction companies are exploring other sectors to find new growth engines amid deteriorating profitability in the housing industry...
Mar 08, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Bioepis launches ARMD biosimilar drug in Germany, Canada
Samsung Bioepis Co., a South Korean biosimilar firm, announced on Sunday that it has recently launched a new biosimilar drug called SB11 for the tre...
Mar 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion ex-Chairman Seo set to return to management; group stocks rally
South Korea’s biosimilar giant Celltrion Group’s founder and Honorary Chairman Seo Jung-jin is readying to return to management just two...
Mar 03, 2023 (Gmt+09:00)
-
Pension funds
Inflation casts shadow over S.Korea NPS' hedging strategies
South Korea’s National Pension Service (NPS), with 920.4 trillion won ($694.6 billion) in assets as of November 2022, faces growing concerns o...
Feb 28, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea’s stent maker Taewoong Medical acquired by Olympus for $370 million
Japanese medical device company Olympus on Saturday said it will wholly acquire South Korea’s Taewoong Medical, a maker of gastrointestinal (G...
Feb 27, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
Why SM emerged as hot battlefield between HYBE, Kakao
SM Entertainment Co., a South Korean music label widely credited as the pioneer of K-pop, has emerged as a new battlefield between HYBE Co., the age...
Feb 10, 2023 (Gmt+09:00)
-
Bio & Pharma
Prestige Bio's Herceptin biosimilar proves equivalence in clinical trials
Prestige Biopharma, a South Korean biopharmaceutical developer, said on Tuesday that the final analysis of phase 3 clinical trial on the anti-cancer...
Feb 08, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare launches anti-cancer biosimilar Vegzelma in Japan
Celltrion Healthcare Co. Ltd. said on Thursday that it launched Vegzelma, a biosimilar to the anti-cancer drug Avastin (active ingredient: bevacizum...
Jan 26, 2023 (Gmt+09:00)
-
Bio & Pharma
HK inno.N to introduce biosimilars for bone disease treatment from Spain
South Korea's biohealth company HK inno.N said on Wednesday that it has signed an agreement with Spanish pharmaceutical company mAbxience SA to intr...
Jan 26, 2023 (Gmt+09:00)
-
Electronics
Carrier’s Korea JV aims to raise sales with cold chain biz
Carrier Global Corp.’s joint venture in South Korea aims to ramp up sales with the cold chain business, the series of actions and equipment ap...
Jan 22, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare lands biosimilar deal in Brazil for 2nd straight year
South Korea's Celltrion Healthcare Co. on Tuesday said that for the second straight year, it landed an order for infliximab, an antibody used to tre...
Jan 11, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion acquires approval to sell Vegzelma in Canada
South Korea's biosimilar heavyweight Celltrion Inc. has obtained permission from the Canadian health ministry to sell anticancer biosimilar Vegzelma...
Jan 05, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Chemicals introduces Tiglutik, treatment for Lou Gehrig's disease
SK Chemicals said on Monday that it is strengthening its portfolio of neurological diseases by introducing Tiglutik (riluzole), Lou Gehrig's disease...
Jan 02, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's Alteogen signs $145 million tech export deal with Swiss company
South Korea's bio company Alteogen Inc. on Friday said it signed its fourth technology export contract since its 2018 development of the human recom...
Dec 30, 2022 (Gmt+09:00)
-
Korean stock market
TIGER KEDI30 ETF tops Korean retail investors’ themed stock buy list
The TIGER KEDI30 ETF has topped the list of the most purchased exchange-traded funds (ETFs) by South Korea’s individual investors in the theme...
Dec 27, 2022 (Gmt+09:00)
-
Food & Beverage
SK expands sustainable food biz with $7.5 mn US investment
SK Inc., the holding company of South Korea’s No. 2 conglomerate SK Group, has expanded its sustainable food business by investing in a US-bas...
Nov 25, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion wins trial against Regeneron for US patent lawsuit over biosimilar
South Korean biopharmaceutical company Celltrion Inc. announced Friday that it won its first trial against New York-based biotech giant Regeneron Ph...
Nov 18, 2022 (Gmt+09:00)
-
Private equity
Korean PE firms struggle with fundraising on illiquidity
South Korean private equity (PE) firms are having trouble fundraising as institutional investors' capital for new investment is drying up amid inter...
Nov 10, 2022 (Gmt+09:00)
-
ASK 2022
Korea Post's insurance arm uses buyout, senior debt as core strategies
Korea Post’s insurance bureau will maintain its core-satellite strategy in private equity and debt investments for both stable revenue streams...
Oct 27, 2022 (Gmt+09:00)
-
Healthcare
Celltrion targets digital healthcare sector with app
Celltrion Inc., South Korea’s biopharmaceutical giant, made a foray into the digital healthcare sector for its future growth by launching a sm...
Oct 05, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion wins sales approval for biosimilar Vegzelma in Japan
Celltrion Inc. secured Japan’s approval for sales of its cancer treatment biosimilar CT-P16, a move to help the South Korean biopharmaceutical...
Sep 27, 2022 (Gmt+09:00)
-
Tech, Media & Telecom
SK Telecom expands business portfolio with quantum tech
South Korea’s top mobile carrier SK Telecom Co. is expanding its business portfolio with quantum technology, even into industries that are unr...
Sep 20, 2022 (Gmt+09:00)
-
Asset management
Meet Wall St. thought leaders at Hankyung conference in NYC
The Korea Economic Daily (KED) is hosting a global financial conference for Korean investors in the heart of New York City in October, where top Wal...
Sep 08, 2022 (Gmt+09:00)
-
Pension funds
Korea's NPS commits to Blackstone's ESG credit platform
The National Pension Service (NPS) of South Korea, has committed capital to Blackstone Credit’s Sustainable Resources Platform to enhance the ...
Aug 25, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion gains sales approval for biosimilar Vegzelma in Europe
Celltrion Healthcare Co., South Korean biopharmaceutical giant Celltrion Inc.'s global marketing affiliate, said on Friday it has obtained the Europ...
Aug 19, 2022 (Gmt+09:00)